United States HR 4106: Responsibility in Drug Advertising Act of 2019

Status: Referred to the Subcommittee on Health. (as of 2019-07-31)

State: United States · Session: 116 · Bill: HR 4106

Subjects: Drug safety, medical device, and laboratory regulation, Marketing and advertising, Prescription drugs

Sponsors: ROSA DELAURO, Chris Pappas, Raul M. Grijalva, Ro Khanna

View United States HR 4106 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.